Trials / Completed
CompletedNCT02635321
MRI and Muscle Involvement in Patients With Mutations in GMPPB
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Limb girdle muscular dystrophies (LGMD) are a very heterogeneous group of muscle disorders characterized by muscle weakness and atrophy of the proximal muscles of the shoulder and pelvic girdles. LGMD is classified based on its inheritance pattern and genetic cause into more than 31 different types. A new type - type 2T has been found. The genetic cause of type 2T is mutations in Guanosine Diphosphate (GDP)-mannose pyrophosphorylase B (GMPPB). Mutations in GMPPB can also cause Congenital muscular dystrophies (CMD). Only 41 patients with mutations in GMPPB has been reported. In this study, the investigators examine five new cases with the LGMD phenotype. The primary aim is to examine the muscle involvement using MRI.
Conditions
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2015-12-18
- Last updated
- 2016-04-06
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02635321. Inclusion in this directory is not an endorsement.